A report from AARP shows that prices of brand-name prescription drugs and specialty medicines commonly used by Medicare patients increased nearly 10% for the year that ended in March, while generic-drug prices declined. The Pharmaceutical Research and Manufacturers of America dismissed the data as "misleading," saying the report excludes "discounts and rebates generally negotiated between drug manufacturers and payers."

Related Summaries